Huber Needles Market Size

  • Report ID: 319
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Huber Needles Market Size

Huber Needles Market size was valued at USD 51.44 million in 2024 and is poised to cross USD 163.07 million by the end of 2037, registering more than 9.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of huber needles is estimated at USD 55.27 million.

The growth of the market is primarily attributed to the worldwide increasing prevalence of chronic renal diseases. For instance, chronic kidney disease is a degenerative disorder that affects more than 12% of the global population, that represents more than 900 million people.

Huber needles are hollow needles that have slant tip to make it easy to go throw skin. These needles are primarily used for recurrent access to veins for blood extraction and the infusion of blood products, medicine, and nutritional solutions in combination with a point implanted in the body of a persistently ill patient. Increasing use of huber needles for the treatment of hepatitis and HIV is fueling up the growth of the huber needles market over the forecast period. As per the statistics provided by the World Health Organization (WHO), more than 350 million people worldwide are still surviving with the risk of hepatitis B or C infection.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 319
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of huber needles is estimated at USD 55.27 million.

The huber needles market size was valued at USD 51.44 million in 2024 and is poised to cross USD 163.07 million by the end of 2037, registering more than 9.2% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of needle stick injuries in healthcare workers, global surge in HIV prevalence, and increasing ratio of obesity in people across the globe will drive the market growth.

North America industry is likely to hold majority revenue share by 2037, driven by significant propagation in chemotherapy and dialysis processes on account of major surge in lifestyle diseases, such as, diabetes, along with increasing count of various chronic disorders in the region.

The major players in the market include B. Braun Medical Inc, .ICU Medical, Inc., Baxter International, Inc., Nipro Medical Corporation, Becton, Dickinson and Company, AngioDynamics, Inc., Vygon SAS, EXELINT International, Co., Medtronic, Terumo Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample